Literature DB >> 2900036

Vasodilator response to dopamine in the ferret pulmonary circulation.

P Gorman1.   

Abstract

1. The isolated perfused lung of the ferret was used to study the effects of dopamine receptor agonists and antagonists. Under constant flow, a fall in pulmonary artery pressure reflects a vasodilator response. Since tone is normally low, agonists were given during hypoxic pulmonary vasoconstriction to enable detection of dilator responses. 2. Vasodilator responses were produced by bolus doses of dopamine over the range 0.1 to 5.0 micrograms kg-1, and by the selective DA1 agonist SK&F 38393 (1-phenyl-7,8-dihydroxy-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride). 3. The dopamine response was blocked by low doses of the selective DA1-antagonist SCH23390 (R-(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7- ol maleate), and by sulpiride. 4. The vasodilator response to the relatively selective DA2-agonist N,N-di-n-propyl dopamine occurred only at high dose and was incompletely blocked by the selective DA2 antagonist domperidone at a cumulative dose of 10 mg kg-1. 5. Thus dopamine receptors of the DA1 type may mediate vasodilatation in the ferret pulmonary circulation, but no evidence was obtained for the existence of DA2-receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900036      PMCID: PMC1853922          DOI: 10.1111/j.1476-5381.1988.tb11517.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Effect of dopamine and isoproterenol on pulmonary vascular resistance.

Authors:  R M Mentzer; C Alegre; S P Nolan
Journal:  Rev Surg       Date:  1976 Nov-Dec

2.  Factors causing and reversing vasoconstriction in unventilated lung.

Authors:  P Howard; G R Barer; B Thompson; P M Warren; C J Abbott; I P Mungall
Journal:  Respir Physiol       Date:  1975-09

3.  Peripheral pre- and post-synaptic dopamine receptors: are they different from dopamine receptors in the central nervous system?

Authors:  L I Goldberg; J D Kohli
Journal:  Commun Psychopharmacol       Date:  1979

4.  Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors.

Authors:  J D Kohli; A B Weder; L I Goldberg; J Z Ginos
Journal:  J Pharmacol Exp Ther       Date:  1980-05       Impact factor: 4.030

5.  Effects of dopamine on isolated canine coronary arteries.

Authors:  N Toda; L I Goldberg
Journal:  Cardiovasc Res       Date:  1975-05       Impact factor: 10.787

6.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

7.  Sulpiride: a weak antagonist of norepinephrine and 5-hydroxytryptamine.

Authors:  J D Kohli; L D Cripe
Journal:  Eur J Pharmacol       Date:  1979-06-15       Impact factor: 4.432

8.  N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist.

Authors:  J D Kohli; L I Goldberg; P H Volkman; J G Cannon
Journal:  J Pharmacol Exp Ther       Date:  1978-10       Impact factor: 4.030

9.  Depression of hypoxic pulmonary vasoconstriction in the dog by dopamine and isoprenaline.

Authors:  J L Marin; C Orchard; M K Chakrabarti; M K Sykes
Journal:  Br J Anaesth       Date:  1979-04       Impact factor: 9.166

10.  Effects of alpha adrenergic blockade and tissue catecholamine depletion on pulmonary vascular response to hypoxia.

Authors:  E D Silove; R F Grover
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808

View more
  1 in total

1.  Dopamine receptor blockade improves pulmonary gas exchange but decreases exercise performance in healthy humans.

Authors:  Vincent Tedjasaputra; Tracey L Bryan; Sean van Diepen; Linn E Moore; Melissa M Bouwsema; Robert C Welsh; Stewart R Petersen; Michael K Stickland
Journal:  J Physiol       Date:  2015-06-08       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.